Back to results
US 2013/0172356 A1Published application
Combination of egcg or methylated egcg and a pde inhibitor
AssigneeKyushu University, National University Corporation
InventorHirofumi Tachibana
Life of this patent
Estimating the term…
Abstract
Disclosed is a medicament characterized by the combination of: epigallocatechin gallate, methylated epigallocatechin gallate, or a pharmacologically permitted salt thereof; and a phosphodiesterase inhibitor.
Claims6
A pharmaceutical composition comprising a combination of epigallocatechin gallate or a methylated epigallocatechin gallate or a pharmaceutically acceptable salt thereof and a phosphodiesterase inhibitor.
A kit for use in treatment of cancer, allergy, obesity, arteriosclerosis, inflammation, or muscle atrophy, the kit comprising:
- a) a first unit dosage form containing epigallocatechin gallate, a methylated epigallocatechin gallate, or a pharmaceutically acceptable salt thereof;
- b) a second unit dosage form containing a phosphodiesterase inhibitor;
- and
- c) a container device for containing the first unit dosage form and the second unit dosage form.
1 more element
Dependencies are inferred from the claim text.